Increased Psychiatric Morbidity in Men With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 37 of the 40 references it cites were found in a registry or an index.
Abstract
CONTEXT: Reports on psychiatric morbidity in males with congenital adrenal hyperplasia (CAH) are lacking. OBJECTIVE: The aim was to study psychiatric disorders in CAH males. DESIGN, SETTING, AND PARTICIPANTS: We studied males with CAH (21-hydroxylase deficiency, n = 253; CYP21A2 mutations known, n = 185), and compared them with controls (n = 25 300). Data were derived through linkage of national population-based registers. We assessed the subgroups of CYP21A2 genotype separately (null, I2splice, I172N, P30L, and NC), as well as outcomes before and after the introduction of national neonatal screening in 1986. MAIN OUTCOME MEASURES: Psychiatric disorders including attempted and completed suicide (suicidality) were reviewed. RESULTS: Psychiatric disorders (suicidality not included), suicidality, and alcohol misuse were increased in CAH males compared with controls (odds ratios, 1.5, 2.3, and 1.9; 95% confidence intervals, 1.1-2.2, 1.1-5.0, and 1.0-3.5, respectively). In the null genotype group, no increased rates were seen; in the I2splice group, psychiatric disorders, personality disorders, and alcohol misuse were increased; in the I172N group, suicide attempt and drug misuse were increased; and in the P30L and NC groups, psychotic disorders were increased. In CAH males born before the neonatal screening, the rates of psychiatric disorders and suicidality were increased, but only psychotic disorders increased in those born afterward. There was no increased risk for any neurodevelopmental disorder. CONCLUSIONS: CAH males have an increased psychiatric morbidity. Psychiatric morbidity was not raised in the most severe genotype group. Late diagnosis of CAH may explain some of the findings. Those born before the introduction of neonatal screening were more affected, which may be explained by the higher age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mental health of patients with CAH is another example; although most studies focus on females, increased psychiatric symptomatology in both sexes mirrors observations for a wide range of chronic medical conditions (547,594-597).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [595]
In the citing paper
“Epidemiological national registry studies in Sweden have shown that females and males with CAH had an elevated risk of receiving any psychiatric diagnosis [OR, 1.5 (1.1 to 2.2)].”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [378]
In the citing paper
“Girls and women with CAH had an increased risk of reaction to extreme stress and adjustment disorders [OR 2.1, (1.3 to 3.6)] and of alcohol abuse [OR, 2.8 (1.7 to 4.7)] compared with those without the disorder, with the highest risk among those with the most severe genotype.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [378]
In the citing paper
“For boys and men, there were increased rates of reported suicides and suicide attempts [OR, 2.3 (1.1 to 5.0)] and alcohol abuse [OR, 1.9 (1.0 to 3.5)] (377, 378).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [378]
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Why are autism spectrum conditions more prevalent in males?
Baron-Cohen, S., Lombardo, M. V., Auyeung, B., Ashwin, E., Chakrabarti, B., & Knickmeyer, R. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001081 · Cited by 754
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Psychiatric Adverse Effects of Corticosteroids
Warrington, T. P., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1361 · Cited by 611
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Congenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Frisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276
Self-citation
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationCaring for individuals with a difference of sex development (DSD): a Consensus Statement
Cools, M., Nordenström, A., Robeva, R., Hall, J., Westerveld, P., Flück, C., Köhler, B., Berra, M., Springer, A., Schweizer, K., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0010-8 · Cited by 461
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Falhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Self-citationIncreased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196
Self-citationNordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Self-citationClinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Self-citationSex hormones in alcohol consumption: a systematic review of evidence
Erol, A., Ho, A. M., Winham, S. J., & Karpyak, V. M. (2017) · Addiction Biology · doi:10.1111/adb.12589 · Cited by 142
“…exposure to excessive prenatal testosterone levels in utero caused by congenital adrenal hyperplasia or the presence of male co-twin was found to be associated with either increased (Falhammar et al. 2014) or decreased risk (Lenz et al. 2012) of alcohol dependence later in life, respectively.”
BackgroundResultInfluentialEngberg, H., Butwicka, A., Nordenström, A., Hirschberg, A. L., Falhammar, H., Lichtenstein, P., Nordenskjöld, A., Frisén, L., & Landén, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.017 · Cited by 132
“We recently reported that men with CAH have an increased rate of psychiatric disorders, suicides or suicide attempts, and substance misuse (Falhammar et al., 2014a) The primary purpose of this study was to estimate the frequency of psychiatric disorders in a large unbiased cohort of girls and women…”
BackgroundSelf-citationFalhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Self-citationHow early hormones shape gender development
Berenbaum, S. A., & Beltz, A. M. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.11.011 · Cited by 112
“Boys and men with CAH also had higher rates of psychiatric disorder than controls [24].”
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109
“Similarly higher replacement doses of hydrocortisone have been associated with lower quality of life (QoL) in patients with adrenal insufficiency (40), and lower psychological wellbeing (41).”
BackgroundJenkins-Jones, S., Parviainen, L., Porter, J., Withe, M., Whitaker, M. J., Holden, S. E., Morgan, C. L., Currie, C. J., & Ross, R. J. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0895 · Cited by 85
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Self-citationHealth status in 1040 adults with disorders of sex development (DSD): a European multicenter study
Falhammar, H., Claahsen-van der Grinten, H., Reisch, N., Slowikowska-Hilczer, J., Nordenström, A., Roehle, R., Bouvattier, C., Kreukels, B. P. C., Köhler, B., & _, _. (2018) · Endocrine Connections · doi:10.1530/ec-18-0031 · Cited by 76
Self-citationAl Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
Self-citationCognitive impairment in adolescents and adults with congenital adrenal hyperplasia
Karlsson, L., Gezelius, A., Nordenström, A., Hirvikoski, T., & Lajic, S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13441 · Cited by 61
Self-citationFalhammar, H., Frisén, L., Norrby, C., Almqvist, C., Hirschberg, A. L., Nordenskjöld, A., & Nordenström, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01139 · Cited by 60
Self-citationThe androgen model of suicide completion
Lenz, B., Röther, M., Bouna-Pyrrou, P., Mühle, C., Tektas, O. Y., & Kornhuber, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.003 · Cited by 62
Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review
Daae, E., Feragen, K. B., Waehre, A., Nermoen, I., & Falhammar, H. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00038 · Cited by 50
Self-citationDaae, E., Feragen, K. B., Nermoen, I., & Falhammar, H. (2018) · Endocrine · doi:10.1007/s12020-018-1723-0 · Cited by 45
Self-citationLong-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 50
“9 compared to controls [33, 59,60], with increased depression [61], alcohol misuse [59,60] and suicidality [30,59].”
Self-citationMental health status of individuals with sexual development disorders: A review
Bohet, M., Besson, R., Jardri, R., Manouvrier‐Hanu, S., Catteau-Jonard, S., Cartigny, M., Aubry, E., Leroy, C., Frochisse, C., & Medjkane, F. (2019) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2019.04.010 · Cited by 43
Falhammar, H., Frisén, L., Hirschberg, A. L., Nordenskjöld, A., Almqvist, C., & Nordenström, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab712 · Cited by 42
Self-citationReisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 36
“Several groups showed impaired health status in 21-OHD [6], as well as impaired survival [7].”
BackgroundPsychosocial well-being in Dutch adults with disorders of sex development
de Neve-Enthoven, N. G. M., Callens, N., van Kuyk, M., van Kuppenveld, J. H., Drop, S. L. S., Cohen‐Kettenis, P. T., & Dessens, A. B. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.03.005 · Cited by 44
Sewell, R. L., Buchanan, C., Davis, S., Christakis, D., Dempsey, A. F., Furniss, A., Kazak, A. E., Kerlek, A. J., Magnusen, B., Pajor, N. M., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.08.066 · Cited by 34
Kim, J. H., Choi, S., Lee, Y. A., Lee, J., & Kim, S. G. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1328 · Cited by 33
“The Swedish group also identified an increased risk for any psychiatric risk in men and women with CAH before the introduction of neonatal screening [30,31].”
BackgroundLong‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
Health-related quality of life in primary and secondary adrenal insufficiency
Aulinas, A., & Webb, S. M. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.963559 · Cited by 32
“Psychiatric disorders especially in patients with severe degrees or genotypes of CAH have also been described [33,34].”
BackgroundPrenatal sex hormones and behavioral outcomes in children
Day, D. B., Collett, B. R., Barrett, E. S., Bush, N. R., Swan, S. H., Wang, C., & Sathyanarayana, S. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104547 · Cited by 28
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Self-citationHarasymiw, L. A., Grosse, S. D., Cullen, K. R., Bitsko, R. H., Perou, R., & Sarafoglou, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1129584 · Cited by 25
“1 among those with the simple virilizing form, while the other study found no difference among female patients (18, 19).”
BackgroundResultFalhammar, H., Frisén, L., Hirschberg, A. L., Nordenskjöld, A., Almqvist, C., & Nordenström, A. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00122 · Cited by 23
Self-citationKocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Self-citationChallenges Waiting for an Adult with DSD
Nowotny, H. F., & Reisch, N. (2022) · Hormone Research in Paediatrics · doi:10.1159/000527433 · Cited by 25
Hypogonadotrophic hypogonadism, delayed puberty and risk for neurodevelopmental disorders
Gotby, A. O., Söder, O., Frisén, L., Serlachius, E., Bölte, S., Almqvist, C., Larsson, H., Lichtenstein, P., & Tammimies, K. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12803 · Cited by 25
Self-citationLajić, S., Karlsson, L., Zetterström, R. H., Falhammar, H., & Nordenström, A. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030068 · Cited by 25
“Psychiatric diseases seem more common [13,16,32,33], especially depression [13,32–34], alcohol misuse [32,33] and suicidality [16,32], which can be interpreted as stress related.”
BackgroundSelf-citationMusa, N., Asem, N., Basyony, S., & Fawaz, L. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0345 · Cited by 21
AbdAlmageed, W., Mirzaalian, H., Guo, X. J., Randolph, L. M., Tanawattanacharoen, V. K., Geffner, M. E., Ross, H. M., & Kim, M. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22199 · Cited by 23
Shafaay, E. A., Aldriweesh, M. A., Aljahdali, G. L., Babiker, A. M. I., Alomar, A. O., Alharbi, K. M., Aldalaan, H., Alenazi, A. O., Alangari, A. S., Alsagheir, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1122435 · Cited by 19
“In particular, males with CAH have fewer chances of having a lifetime partner and often experience erectile dysfunction, decreased sexual activity, and reduced fertility, which leads to substantial psychological issues (25, 27).”
BackgroundSteroid Metabolites Support Evidence of Autism as a Spectrum
Gasser, B. A., Kurz, J., Dick, B., & Mohaupt, M. G. (2019) · Behavioral Sciences · doi:10.3390/bs9050052 · Cited by 19
“Interestingly, individuals with 21-hydroxylase deficiency have an increased risk of psychiatric disorders with the highest risk among those with the most severe genotype and co-occurrence of CAH and autistic disorders [28].”
BackgroundGrosse, S. D., & Vliet, G. V. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6040082 · Cited by 22
“Multiple studies, including a large-scale Swedish registry linked to a national patient database, have found no indication of intellectual disability due to CAH complications, with or without screening [55,56].”
Backgroundder Grinten, H. L. C., Adriaansen, B. P. H., & Falhammar, H. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae718 · Cited by 19
Self-citationHormonal responses in gambling versus alcohol abuse: A review of human studies
Li, Y., Ramoz, N., Derrington, E. A., & Dreher, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109880 · Cited by 19
Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Verhees, M. J. M., Engels, M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., Falhammar, H., Nordenström, A., Webb, E. A., Richter-Unruh, A., Bouvattier, C. M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626646 · Cited by 19
“The findings suggest that psychological wellbeing does not seem to be largely affected in men with CAH, which is in contrast to previously reported higher prevalence rates of psychiatric morbidity in men with CAH (26).”
ResultSelf-citationCharacteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Kocova, M., Concolino, P., & Falhammar, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.788812 · Cited by 15
“In contrast, in males with the In2G genotype, psychiatric disorders, personality disorders, and alcohol misuse were increased as compared with the null genotype (89).”
BackgroundSelf-citationKung, K. T. F., Spencer, D., Pasterski, V., Neufeld, S., Hindmarsh, P. C., Hughes, I. A., Acerini, C. L., & Hines, M. T. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.004 · Cited by 16
Righi, B., Ali, S., Bryce, J., Tomlinson, J., Bonfig, W., Baronio, F., Costa, E. C., Guaragna‐Filho, G., T'Sjoen, G. G., Cools, M., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03330-w · Cited by 15
Self-citationNordenström, A., Svensson, J., Lajić, S., Frisén, L., Nordenskjöld, A., Norrby, C., Almqvist, C., & Falhammar, H. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01199 · Cited by 15
Self-citationCaring for individuals with a difference of sex development (DSD): a Consensus Statement
Cools, M., Nordenström, A., Robeva, R. N., Hall, J., Westerveld, P., Flück, C., Kohler, B., Berra, M., Springer, A., SCHWEIZER, K. W., et al. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.6.20 · Cited by 14
Self-citationGodfrey, L. M. (2020) · Journal of Health Psychology · doi:10.1177/1359105320909863 · Cited by 14
“Studies that have examined mental health outcomes specifically have primarily investigated women with a 46,XX condition called congenital adrenal hyperplasia (CAH; e.g., Berenbaum et al., 2004; Engberg et al., 2015; Falhammar et al., 2014), as this is the most prevalent DSD condition.”
BackgroundMessina, V., Hirvikoski, T., Karlsson, L., Vissani, S., Wallensteen, L., Ortolano, R., Balsamo, A., Nordenström, A., & Lajić, S. (2020) · Endocrine · doi:10.1007/s12020-020-02244-1 · Cited by 11
Self-citationManagement of congenital adrenal hyperplasia: beyond conventional glucocorticoid therapy
Khattab, A., & Marshall, I. H. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000780 · Cited by 14
“Affected males also had higher rates of psychiatric disorders, substance abuse and suicide [40].”
Lao, Q., Jardin, M. D., Jayakrishnan, R., Ernst, M., & Merke, D. P. (2018) · Human Genetics · doi:10.1007/s00439-018-1959-z · Cited by 12
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
“Finally, the correlation between genotype and other long-term outcomes, such as mortality [93], psychiatric diseases [94, 95], cardiometabolic complications [96, 97], auto-immune diseases [98], fractures [19], injuries and accidents [99], were more unclear.”
Self-citationEndocrine Disorders and Psychiatric Manifestations
Salvador, J., Gutierrez, G., Llavero, M., Gargallo, J., Escalada, J., & López, J. (2019) · Endocrinology · doi:10.1007/978-3-319-66362-3_12-1 · Cited by 15
Gotby, A. O., Nordenström, A., Falhammar, H., Nordenskjöld, A., Hirschberg, A. L., Frisén, L., Landén, M., & Lichtenstein, P. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.008 · Cited by 14
“This process has been described in detail previously (Falhammar et al., 2014).”
MethodSelf-citationNordenström, A., Butwicka, A., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., Falhammar, H., & Frisén, L. (2016) · Clinical Endocrinology · doi:10.1111/cen.13242 · Cited by 11
Self-citationHarasymiw, L. A., Grosse, S. D., & Sarafoglou, K. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa152 · Cited by 13
“In our approach, we augmented our CAH claims algorithm from previously published work [34, 48, 49] to include a requirement of at least 2 filled glucocorticoid prescriptions.”
BackgroundMethodClinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan
Yatsuga, S., Amano, N., Nakamura-Utsunomiya, A., Kobayashi, H., Takasawa, K., Nagasaki, K., Nakamura, A., Nishigaki, S., Numakura, C., Fujiwara, I., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0011 · Cited by 9
Bancos, I., Kim, H., Cheng, H. K.-H., Rodríguez-Lee, M., Coope, H., Cicero, S., Goldsmith, H., Lin, V. H., & Jeha, G. S. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2450423 · Cited by 9
“…quality of life has been reported in patients with CAH, along with higher risks for developing psychiatric complications, including depression, alcohol abuse, stress, and adjustment disorders, which have been associated with both adrenal androgen excess as well as GC exposure [24,59,61,117–124].”
Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia
Jacob, M., Lin‐Su, K., Catarozoli, C. R., Thomas, C., Poppas, D. P., & Lekarev, O. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-2-10 · Cited by 8
“In adult men with CAH, Falhammar et al. (11) found that the risk of psychiatric morbidity increased in men born before the introduction of CAH newborn screening, possibly due to prolonged androgen exposure.”
BackgroundEndocrine Disorders and Psychiatric Manifestations
Salvador, J., Gutierrez, G., Llavero, M., Gargallo, J., Escalada, J., & López, J. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_12 · Cited by 13
Doktur, H., Tanıdır, C., Güneş, H., Aytemiz, T., Durcan, G., Önal, H., & Kutlu, E. (2021) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2021.365 · Cited by 7
“7) 1 (20) Generalized anxiety disorder 1 (4) 0 (0) 0 (0) Depressive disorders 2 (8) 0 (0) 1 (20) Tic disorders 4 (16) 1 (6.”
Falhammar, H., Hirschberg, A. L., Nordenskjöld, A., Larsson, H., & Nordenström, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad624 · Cited by 5
Self-citationNeurological Complications of Endocrine Disease
Carvalho, K. S., Grunwald, T., & Luca, F. D. (2016) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2016.12.006 · Cited by 8
Changes in resting-state functional connectivity in patients with congenital adrenal hyperplasia
Messina, V., Westeinde, A. V., Padilla, N., & Lajić, S. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103081 · Cited by 5
“2 verbal and visuo-spatial working memory, lower intelligence and an increased risk of psychiatric disorders, especially in patients with the most severe salt-wasting (SW) phenotype (Idris et al., 2014; Falhammar et al., 2014; Johannsen et al., 2006; Browne et al., 2015; Karlsson et al., 2017).”
Clinical practice guidelines for the management of differences of sex development in Japan
Ishii, T., Kashimada, K., Kawai, M., Itonaga, T., Iwasa, T., Nakamura‐Utsunomiya, A., Ozaki, K., Kawamura, K., Kanno, J., Koh, J. R. D., et al. (2025) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2025-0073 · Cited by 6
“C lin P ediatr E ndocrinol doi: 10.1297/cpe.2025-0073 Individuals with 21-hydroxylase deficiency demonstrate a higher risk of mental disorders and stress-related diseases, depending on age at diagnosis, treatment outcomes, and types of glucocorticoid preparations (172, 173).”
InfluentialLangzeitmorbidität beim adrenogenitalen Syndrom
Tschaidse, L., Quitter, F., Hübner, A., & Reisch, N. (2022) · Der Internist · doi:10.1007/s00108-021-01223-6 · Cited by 4
“Hier sind insbesondere ein vermehrter Substanzmissbrauch und Depressionen zu verzeichnen [12, 14].”
Genome-wide investigation of DNA methylation in congenital adrenal hyperplasia
Karlsson, L., Barbaro, M., Ewing, E., Gómez-Cabrero, D., & Lajić, S. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105699 · Cited by 5
Paparella, R., Panvino, F., Pucarelli, I., Niceta, M., Spaziani, M., Spalice, A., Pisani, F., Ardizzone, I., & Tarani, L. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06673-w · Cited by 4
“Nevertheless, certain subgroups of males with CAH, particularly those diagnosed later in life, have shown elevated rates of psychiatric comorbidities, including psychotic disorders and substance use disorders [18, 32].”
Steroid 21-hydroxylase gene variants and late-life depression
Ancelin, M., Norton, J. L., Ritchie, K. A., Chaudieu, I., & Ryan, J. L. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05616-6 · Cited by 3
“Altered cortisol and sex steroid levels and psychiatric disorders have been reported in clinical studies of young adults with 21-hydroxylase deficiency [11, 12], especially in women [13].”
BackgroundAdolescent Personality Risk Factors for Tobacco Smoking and Alcohol Misuse in Adult Men
Czaderny, K. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1741635 · Cited by 4
“Higher prenatal androgen loads were identified as being associated with alcohol dependence (Lenz et al., 2012; Ellingson et al., 2013; Falhammar et al., 2014; Lenz et al., 2017).”
BackgroundLiang, M. C., Fraga, N. R., Minaeian, N., Herting, M. M., Geffner, M. E., Bachega, T. A. S. S., & Kim, M. S. (2025) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2025.2024-11-9 · Cited by 2
“Patients with classical CAH exhibit a higher lifetime prevalence of depression, as well as an increased prevalence of anxiety in youth and adult-onset psychiatric disorders (2,3).”
A Case of Prenatally Diagnosed Congenital Adrenal Hyperplasia With Brain Morphometric Differences
Rajagopalan, V., Overholtzer, L. N., Kim, W. S., Wisnowski, J. L., Miller, D. A. W., Geffner, M. E., & Kim, M. S. (2022) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096221105245 · Cited by 2
Lind‐Holst, M., Hansen, D., Main, K. M., Juul, A., Andersen, M., Dunø, M., Rasmussen, Å. K., Jørgensen, N., Gravholt, C. H., & Berglund, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae780 · Cited by 2
Liu, Y., Gang, X., Gao, Y., & Wang, G. (2025) · Endocrine · doi:10.1007/s12020-025-04237-4 · Cited by 2
“In relation to BIP, previous research has documented increased levels of depression and anxiety in individuals with CAH [48].”
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_59 · Cited by 2
Prior to versus after Metformin Treatment—Effects on Steroid Enzymatic Activities
Gasser, B. A., Escher, G., Calin, A.-E., Deppeler, M., Marchon, M., Mistry, H. D., Kurz, J., & Mohaupt, M. G. (2023) · Life · doi:10.3390/life13051094 · Cited by 2
“Interestingly, individuals with 21-hydroxylase deficiency (one entity of CAH) have an increased risk of psychiatric disorders; this deficiency was also linked to autism [16,17].”
BackgroundFamily planning and preimplantation testing: family experiences in congenital adrenal hyperplasia
Sandy, J., Betts, G. A., Harper, J. L., Nevin, S. M., Deans, R., & Neville, K. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1482902 · Cited by 1
Verde, V., Wörther, H., Kühle, A., Grunwald, P., Tschaidse, L., Chojnacki, M., Ilmberger, S., Berente, S., Reisch, N., & Krämer, U. (2026) · Hormones and Behavior · doi:10.1016/j.yhbeh.2026.105953 · Cited by 1
Congenital adrenal hyperplasia. Role of dentist in early diagnosis
Cosola, M. D., Spirito, F., Zhurakivska, K., Nocini, R., Lovero, R., Sembronio, S., Santacroce, L., Brauner, E., Storto, G., Muzio, L. L., et al. (2022) · Open Medicine · doi:10.1515/med-2022-0524 · Cited by 2
Ernst, M., Cogo‐Moreira, H., Desai, J., & Merke, D. P. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115623 · Cited by 1
“Of note, these data contrast with literature findings indicating higher rates of anxiety and depression in CAH individuals compared to non-CAH individuals in population-based studies (de Vries et al., 2019; Engberg et al., 2015; Falhammar et al., 2014; Jenkins-Jones et al., 2018).”
Зелінська, Н. Б. (2019) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
Nationellt miljökvalitetsmål på lokal nivå
Engkvist, F. (2011)
Congenital adrenal hyperplasia associated with mental disorders: A case report
Grujičić, R., Maslak, J., Stupar, S., & Pejovic-Milovancevic, M. M. (2020) · Psihijatrija danas · doi:10.5937/psihdan2001057g
21-Hydroxylase Deficiency: Clinical and Biochemical Aspects
Nordenström, A., & Lajić, S. (2019) · Encyclopedia of Endocrine Diseases · doi:10.1016/b978-0-12-801238-3.65208-x
Self-citationCongenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-2
Sandler, C. N., & SHANK, K. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-54281-7_40
Breakthroughs in Congenital Adrenal Hyperplasia Care – Hope on the Horizon
Raizada, N., & Madhu, S. V. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_333_24
“[19] Increased prevalence of injuries and accidents has also been seen in CAH patients, especially females.”
BackgroundPsychiatric Morbidity Associated in Individuals with Disorders of Sex Development
Subramanyam, A. A., Somaiya, M. P., & Khar, P. B. (2024) · Springer eBooks · doi:10.1007/978-981-97-1639-5_49
21-Hydroxylase deficiency: Clinical and biochemical aspects
Nordenström, A., & Lajić, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00171-0
Self-citationHyperplasie congénitale des surrénales : formes précoces
Levaillant, L., Bouhours‐Nouet, N., Rouleau, S., Amsellem‐Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(25)85172-x
Clinical practice guidelines for the management of differences of sex development in Japan
Ishii, T., Kashimada, K., Kawai, M., Itonaga, T., Iwasa, T., Nakamura‐Utsunomiya, A., Ozaki, K., Kawamura, K., Kanno, J., Koh, J. R. D., et al. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej25-0392 · Cited by 1
Additional file 1 of Steroid 21-hydroxylase gene variants and late-life depression
Ancelin, M., Norton, J. L., Ritchie, K. A., Chaudieu, I., & Ryan, J. L. (2021) · Figshare · doi:10.6084/m9.figshare.14677148
Hiperplasia suprarrenal congénita: formas precoces
Levaillant, L., Bouhours-Nouet, N., Rouleau, S., Amsellem-Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pediatría · doi:10.1016/s1245-1789(25)51124-1
Update in Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Bouliari, A., Lekarev, O., & Lin‐Su, K. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.01.001
Metadata
- Authors
- Falhammar, H., Butwicka, A., Landén, M., Lichtenstein, P., Nordenskjöld, A., Nordenström, A., & Frisén, L.
- Affiliations
- Karolinska University Hospital (SE)
- Medical University of Warsaw (PL)
- Karolinska Institutet (SE)
- Corresponding author
- Falhammar, Henrik
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-03-01
- Volume
- 99
- Issue
- 3
- Pages
- E554-E560
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2100099972
- Cited by
- 98
- References
- 40
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 16 · 2019: 11 · 2018: 11 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 2
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Karolinska Institutet
- Stockholms Läns Landsting
- Vetenskapsrådet (523-2011-3807)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Social Psychology › LGBTQ Health, Identity, and Policy
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, psychiatric morbidity, suicidality, alcohol abuse, psychosis, personality disorders, drug abuse, newborn screening, delayed diagnosis
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Aged, Aged, 80 and over, Alcoholism, Mental Disorders, Child, Child, Preschool, Genotype, Humans, Infant, Male, Middle Aged, Steroid 21-Hydroxylase, Suicide, Sweden, Case-Control Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.